Whether decaf moves your blood pressure depends on whether you already drink coffee, and the two best trials point in opposite directions. For habitual coffee drinkers, switching from regular to decaf produces a small but real fall: van Dusseldorp 1989 (n=45, Netherlands, 12 weeks) measured a 1.5 mmHg systolic and 1 mmHg diastolic drop. For people who rarely drink coffee, the picture flips. Corti et al. (2002, University Hospital Zurich) found a single triple decaf espresso raised systolic pressure by about 12 mmHg an hour later in non-habitual drinkers, with no caffeine to speak of in the cup. Taking the caffeine out doesn’t take the effect out: the compounds doing the work are chlorogenic acids, diterpenes and the few percent of residual caffeine that survives decaffeination.
A note before we go further. This is editorial guidance from a decaf specialist directory, not medical advice. If you have hypertension, ongoing high blood-pressure readings, or you’ve just been told to cut your caffeine, the conversation that matters is with your GP. Decaffeinate.co.uk doesn’t treat high blood pressure. It just helps you find a cup that fits the brief.
What the research actually says
Four studies and a UK charity position carry most of the weight here.
van Dusseldorp et al., 1989 (Hypertension 14(5):563-569). Randomised double-blind crossover, 45 Dutch volunteers, six weeks regular coffee (445 mg caffeine per day), six weeks decaf (40 mg caffeine per day). Replacing caffeinated with decaf produced statistically significant reductions of 1.5 mmHg systolic (p=0.002) and 1.0 mmHg diastolic (p=0.017). The authors’ verbatim conclusion: “In normotensive adults replacement of regular by decaffeinated coffee leads to a real but small fall in blood pressure.” Healthy normotensive volunteers, not a hypertension study. Dutch, not Swiss; the trial gets miscited as Swiss in a few UK roaster blogs.
Corti et al., 2002 (Circulation 106:2935-2940). Within-subject mechanistic study, 15 participants split into 6 habitual and 9 non-habitual coffee drinkers. Each received a triple espresso (caffeinated or decaf), an intravenous caffeine dose, and a saline placebo in separate sessions. The non-habitual drinkers saw systolic blood pressure climb roughly 12 mmHg an hour after the decaf espresso, comparable to the caffeinated effect. Habitual drinkers showed no significant rise from either. The authors’ framing was that “ingredients other than caffeine are responsible for the stimulating effects of coffee on the cardiovascular system”. Small n, single dose, but it’s the cleanest experimental demonstration we have that decaf affects blood pressure through non-caffeine compounds.
D’Elia et al., 2019 (European Journal of Nutrition 58(1):271-280). Meta-analysis of four prospective cohorts, 196,256 participants, 41,184 hypertension cases. A non-linear inverse dose-response: one to two cups a day was not associated with hypertension risk, and three or more cups a day was associated with a small protective effect. The caveat: this is total coffee, not decaf specifically. The decaf-versus-regular comparison in the meta-analytic record is much thinner than the coffee-versus-no-coffee one.
Harvard Health, 2022. Lay synthesis of the above. The line worth carrying forward: “Habitual coffee drinkers become acclimated to these ingredients so their pressures don’t rise more than a point or two, but people who are not used to coffee can expect a temporary rise in their pressures after drinking regular or decaf.” The most actionable single sentence in the literature, and almost nobody on the UK SERP front-loads it.
British Heart Foundation, 2025. Tracy Parker, Senior Dietitian, writing for Heart Matters. The BHF position is that both decaf and caffeinated coffee can sit in a heart-healthy diet, particularly if you’re not loading them with sugar, syrups or cream. The BHF does not engage directly with the Corti non-habitual finding, which is the gap this piece sets out to fill.
Tied together: replace regular with decaf and your blood pressure trends down a little. Try decaf when you don’t normally drink coffee and it might briefly do the opposite. Both are true at the same time. They describe different populations.
Why decaf still affects blood pressure (it isn’t only the caffeine)
The Corti finding is awkward for the “decaf is caffeine-free, so it can’t move blood pressure” story. Three compounds beyond caffeine are doing the work.
Chlorogenic acids (CGAs). The dominant polyphenol family in coffee, retained largely intact through most decaffeination methods. Net effect on blood pressure looks BP-lowering rather than raising. Watanabe et al. 2006 (n=28 mild hypertensives, green coffee bean extract) showed significant reductions in systolic and diastolic BP. Onakpoya et al. 2015 meta-analysis: “Chlorogenic acid intake causes statistically significant reductions in systolic and diastolic blood pressures.” Mechanism: improved endothelial function and increased nitric oxide bioavailability. That’s the lever for the slow, small drop in BP you see with habitual decaf.
Diterpenes (cafestol and kahweol). These don’t move blood pressure directly. They raise LDL cholesterol. Worst in boiled, cafetière and unfiltered espresso preparations. Lowest in paper-filtered drip. Orrje et al., Uppsala University and Chalmers, in Nutrition, Metabolism and Cardiovascular Diseases 2025, measured workplace brewing machines at a median cafestol level of 176 mg/L versus 12 mg/L for paper-filtered home coffee. Decaffeination barely changes this picture; brewing method does. If you’re switching to decaf for cardiovascular reasons and using a cafetière, you’re managing one risk factor while elevating another.
Residual caffeine. The US industry standard, commonly cited as an FDA expectation rather than a codified federal rule, is at least 97% caffeine removal. EU regulation is tighter, capping roasted decaf beans at 0.1% caffeine by dry weight, 0.3% for instant. In a brewed cup that typically lands at 2 to 7 mg per cup against roughly 95 mg in regular coffee. Not nothing, but not enough to matter to most blood pressures most of the time. For a particularly caffeine-sensitive drinker, the residual caffeine in a strong decaf espresso (around 1 to 4 mg per shot) is still real.
So when Corti’s non-habitual drinkers saw a 12 mmHg systolic rise from decaf espresso, the most likely culprits are an acute chlorogenic-acid response combined with the sympathetic nervous-system response to the act of drinking strong coffee. Corti measured muscle sympathetic nerve activity directly and saw the rise sit alongside the BP signal. Caffeine wasn’t doing it because there wasn’t any caffeine to speak of.
Habitual versus non-habitual drinkers (the missing distinction)
If you drink coffee daily, your cardiovascular system has adapted. Adenosine receptors are downregulated. Vascular response to the active compounds in coffee is muted. Switching to decaf removes the small acute pressor effect of caffeine and gradually nudges your average BP down over a few weeks.
If you rarely drink coffee, none of that adaptation is in place. A triple decaf espresso can briefly raise your systolic blood pressure by something in the 10 to 15 mmHg range (Corti 2002, n=15, single dose). Whether that matters clinically depends on baseline. If your resting reading is 118 over 76, it’s a transient bump and you’ll be fine. If you’re already hovering at 140 over 90 and getting nervous about hypertension, the last thing you want is an acute experimental shove in the wrong direction half an hour before you sit down with the BP cuff.
The practical version: if you’ve just been told to cut caffeine and you don’t currently drink coffee, ease into decaf rather than diving in. Start with weaker brews, not triple espressos. Drink with food. Notice your own readings over a couple of weeks before drawing any conclusions about whether it suits you. The “I had decaf at my in-laws and my home reading is high” effect is real for the first cup or two, and it isn’t the in-laws.
Does the decaffeination method matter?
Probably yes, for two reasons: residual caffeine varies a little, and chlorogenic-acid retention varies more.
| Method | Solvent | Residual caffeine | CGA retained | UK availability |
|---|---|---|---|---|
| Swiss Water | Water and activated carbon | 99.9% removed | Higher | Specialty default |
| Sugar cane (EA) | Ethyl acetate from sugar molasses | 97%+ removed | Moderately preserved, slightly lower than water | Growing, common in Colombian decafs |
| CO2 | Supercritical carbon dioxide | 97 to 99% removed | Higher | Limited, premium roasters |
| Methylene chloride | MC, a regulated synthetic solvent | 97%+ removed | Lower | Common in supermarket commodity decaf |
Two things to read off this. First, all four methods get you well below the residual caffeine threshold that would move blood pressure on its own. Second, the methods differ on how much chlorogenic acid survives. Water-process and CO2 preserve more, solvent methods strip more. If you read CGAs as net BP-lowering, which the trial data support, water and CO2 methods are marginally more likely to deliver the small habitual-drinker drop. The differences here are small relative to between-person variation. Don’t pick a decaf method as if it’s a blood-pressure intervention.
Of the 116 decaf coffees we currently curate at Decaffeinate, 25 use Swiss Water. Sugar cane ethyl acetate and CO2 account for most of the rest at the specialty end. Methylene chloride still dominates the supermarket commodity tier we sample, and barely shows up at the specialty roaster end of the directory. If you’re shopping with blood pressure in mind, the practical guidance is the same as if you were shopping on flavour: look at the specialty roaster end of the market, not the supermarket commodity aisle.
UK decafs to try if you’re watching your blood pressure
Eight picks across method, origin and price band. Bias toward Swiss Water and sugar cane EA, with one CO2 option for variety. Tolerance and response is individual, so treat this as a starting list, not a guarantee.
- Caribe Coffee, Swiss Water Decaf SHG. Honduran Strictly High Grown, walnut and toffee. A widely tolerated Swiss Water benchmark from a reliable UK roaster.
- Artisan Roast, Decaf Brazil Swiss Water. Around £9.50, almond, molasses, cocoa. The archetypal Brazilian Swiss Water at a mid price.
- Decadent Decaf, Swiss Water Colombia. UK direct-to-consumer specialist. Easy to buy, easy to repeat, classic Swiss Water profile.
- Origin Coffee, Atlas Decaf. Sugar cane ethyl acetate, medium roast, apple and chocolate. The EA process strips slightly more chlorogenic acid than water does, which can suit drinkers who find Swiss Water still nudges them.
- The Roasting Party, EA Decaf. Hampshire roaster, sugar cane process. Same logic as Origin: lower CGA retention than water methods, with origin-country processing keeping value with the producer.
- Apostle Coffee, The Needle’s Eye Organic Decaf. Sumatran Swiss Water, butterscotch and nutmeg. Breaks the chocolate baseline most Swiss Water decafs sit on, useful if you want flavour variety without leaving the method.
- Belfast Coffee Roasters, Colombia Swiss Water. Caramel, chocolate, apple. Solid Colombian Swiss Water at a reasonable price band.
- Insurgence Coffee, Retreat Decaf. Around £7.50, Brazilian Swiss Water, dark chocolate and nut. The lowest entry point of UK Swiss Water specialty.
The full list lives in the directory, filterable by method and origin. Filter to Swiss Water or sugar cane EA to focus on the styles most likely to deliver the small CGA-led drop you read about in the habitual-drinker trials.
A working approach if you’re switching for BP reasons: pick a Swiss Water from the list, drink it for a fortnight with food, and notice your home readings. If it suits, you have your default. If your readings haven’t shifted, that’s also useful information, and it’s a GP conversation rather than the next bean.
What this article won’t tell you (and where to go instead)
This isn’t medical advice and it isn’t a substitute for measured BP readings over time.
The strongest decaf-versus-regular BP trial we have (van Dusseldorp 1989) is over 30 years old, n=45, ran on healthy normotensive adults, and tells us very little about people already on antihypertensive medication. The cleanest demonstration of “it isn’t only the caffeine” (Corti 2002) is n=15 and a single dose. The chlorogenic-acid retention claims by decaffeination method are directionally supported by trade chemistry but not by a head-to-head RCT comparing all four methods at a fixed origin. We don’t measure CGA content of individual coffees in our directory; we report decaffeination method as a reasonable proxy.
If you have hypertension or you’re titrating a new antihypertensive, the people to talk to are your GP and, where relevant, Blood Pressure UK or the British Heart Foundation. The BHF’s own Heart Matters piece on decaf is sensible, UK-voiced and worth a read. The NHS high blood pressure pages are the right starting point if you’re new to managing it.
Last reviewed: May 2026. We refresh this piece annually, or sooner if a substantively new study lands.
If you’re at the point of swapping cups rather than getting investigated, the directory lists every UK decaf we track, filterable by method, origin and roaster. Filter by Swiss Water or sugar cane EA, pick one that sounds like a coffee you’d want to drink anyway, and start there. The cup of decaf that meaningfully helps your blood pressure is the one you’ll keep drinking.